Second vertical
Greenverse Helmet
A non-invasive neurodiagnostic device that captures biological signals at tissue source — a dimension of information not available to EEG, ECG, MRI or existing electrical diagnostic systems.
Beyond surface electricals.
Signals at tissue source.
Industrial-grade intelligence.
The intended leap
Every diagnostic modality in clinical use measures an electrical signal at the surface, or an image taken at a moment in time. Neither reaches the biology itself.
The Helmet applies sensor intelligence developed in industrial monitoring — the same noise analysis and pattern recognition used in demanding real-world environments — to read biological rather than mechanical signals, at source and in real time.
Neuro-oncology research
Greenverse is applying the platform to neurological disease and cancer-related biological-signal research, including potential use in CNS drug-trial monitoring.
This is an active research direction under clinical partnership. It is not a cleared diagnostic for brain cancer.
Target settings
Intellectual property
PCT international patent filed May 2026, covering 150+ contracting states.
Clinical partnerships
Clinical partnerships established in the UK and Europe. Partner institutions are not publicly named.
Regulatory status
The Greenverse Helmet is investigational and in clinical partnership. It is not a substitute for MRI or standard of care unless and until regulatory clearance is obtained.
Enquiries
We work with a small number of clinical and research partners.
For technical detail, partnership or evaluation enquiries, contact us directly.